期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生物制剂治疗类风湿关节炎进展 被引量：5

Progress of biologics in therapeutics of rheumatoid arthritis
在线阅读 下载PDF
导出
摘要 生物制剂(biologics)是上世纪90年代末开始在风湿性疾病中使用具有明确靶点的新型药物,其主要应用在类风湿关节炎(RA)等疾病的治疗领域。目前研究的药物靶点主要有细胞因子、T细胞、B细胞等。 Biologic agents are an important therapeutic option for treating patients with rheumatoid arthritis（RA） since late 90＇s of last century. Biologic agents have revolutionized the treatment of RA by reducing its signs and symptoms. Current researches of biologics target mainly at cytokines, T and B immunocytes.
作者 鲍春德
机构地区 上海交通大学医学院附属仁济医院风湿科
出处 《实用医院临床杂志》 2007年第3期3-5,共3页 Practical Journal of Clinical Medicine
关键词 生物制剂 类风湿关节炎 治疗 Biologic agents Rheumatoid arthritis Treatment
分类号 R593.22 [医药卫生—内科学]
  • 相关文献

参考文献26

  • 1[1]Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19 year study of radiographic progression[J].Arthritis Rheum,1998,41(9):1571-1582.
  • 2[2]Aletaha D.The rheumatoid arthritis patient in the clinic:comparing more than 1,300 consecutive DMARD courses[J].Rheumatology,2002,41(12):1367-1374.
  • 3[3]Deighton CM.Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)[J].Rheumatology,2005,44:157-163.
  • 4[4]St Clair EW,van der Heijde DMFM,Smolen JS,et al.Combination of infliximab and methotrexate therapy for early rheumatoid arthritis[J].A randomized,controlled trial,Arthritis Rheum,2004,50:3432-3443.
  • 5[5]Breedveld FC,Weisman MH,Kavanaugh AF,et al.Adalimumab plus methotrexate versus methotrexate or adalimumab alone in methotrexate-nave patients with early aggressive rheumatoid arthritis:results of the PREMIER study[J].Arthritis Rheum,2006,54(1):26-37.
  • 6[6]Christine Savage MD,William St Clair MD.New therapeutics in Rheumatoid Arthritis[J].Rheum Dis Clin N Am,2006,32:57-74.
  • 7[7]Mclnnes IB,Gracie JA.Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis[J].Curr Rheumatol Rep,2004,6(5):336-342.
  • 8胡大伟,鲍春德,陈顺乐,古洁若,栗占国,孙凌云,韩星海,倪立青.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎双盲随机多中心对照临床研究[J].中华风湿病学杂志,2005,9(11):664-668. 被引量：86
  • 9[9]Klareskog L,van der Heijde D,de Jager JP,et al.Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis:double-blind randomized controlled trial[J].Lancet,2004,363(9410):675-681.
  • 10[10]Dixon WG,Watson K,Lunt KL.Hyrich,British Society for Rheumatology Biologics Register Control Centre Consortium,A.J.Silman,and D.P.M.Symmons,on behalf of the British Society for Rheumatology Biologics Register.Rates of Serious Infection,Including Site-Specific and Bacterial Intracellular Infection,in Rheumatoid Arthritis Patients Receiving Anti-Tumor Necrosis Factor Therapy[J].ARTHRITIS & RHEUMATISM,2006,54(8):2368-2376.

二级参考文献12

  • 1Feldmann M, Brennan FM, Maini RN. The role of cytokines in rheumatoid arthritis. Ann Rev Immunol, 1996, 14: 397-440.
  • 2Wooley PH, Dutcher J, Widmer MB, et al. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type Ⅱ collagen-induced arthritis in mice. J Immunol,1993, 151: 6602-6607.
  • 3Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum, 1995, 6: 727-735.
  • 4Felson DT, Anderson JJ, Boers M, et al. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum, 1995, 38:727-735.
  • 5American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 1996, 39: 713.
  • 6Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. New Engl J Med, 1994, 330: 1369-1375.
  • 7Firestein GS, Zvaifler NJ. Anticytokine therapy in rheumatoid arthritis. New Engl J Med, 1997, 337: 195-197.
  • 8Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of Etanercept and methotrexate in patients with early rheumatoid arthritis. New Eng J Med, 2000, 343: 1586-1593.
  • 9Moreland LW, Cohen SB, Baumgartner SW, et al. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol,2001, 28: 1238-1244.
  • 10Weinblatt ME, Kremer JM, Bankhurst A, et al. A trial of etanercept: a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate.New Engl J Med, 1999, 340: 253-259.

共引文献85

同被引文献57

引证文献5

二级引证文献38

实用医院临床杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部